ArticleHeliyon2024

Integrated analysis of single-cell and bulk RNA-sequencing identifies a signature based on drug response genes to predict prognosis and therapeutic response in ovarian cancer.

ZhenWei Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.